Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 6 CVD risk profile for study participants completing the post-AHC clinical review (N = 58), (figures are mean [SE] unless otherwise specified)

From: Early identification and preventive care for elevated cardiovascular disease risk within a remote Australian Aboriginal primary health care service

CVD risk factor AHC Review P*
Current smoker N (%) 48 (83%) 45 (78%) 0.51
   Quit smoking N (%) - 6 (13%)  
   Started or recommenced smoking N (%) - 3 (30%)  
Category: cigarettes smoked per day† (N = 41) 3.5 (0.1) 2.6 (0.2) < 0.001
Body mass index kg/m2 (N = 56) 27.3 (0.9) 27.3 (0.8) 0.81
Waist circumference cm (N = 56) 98.3 (1.8) 96.4 (1.8) 0.04
Systolic blood pressure mmHg 128 (2.6) 124 (3.0) 0.2
Total cholesterol mmol/L 5.5 (0.2) 5.3 (0.2) 0.07
HDL cholesterol mmol/L 1.01 (0.03) 1.11 (0.04) 0.001
Ratio of total to HDL cholesterol 5.7 (0.2) 5.0 (0.2) < 0.001
Type two diabetes N (%) 17 (29%) 17 (29%) 1.0
NZGG 5-year CVD risk category‡ 4.5 (0.1) 4.3 (0.2) 0.11
Expected post-AHC absolute 5-year CVD risk % 4.3 (0.4) 4.6 (0.4) < 0.001
Observed post-AHC absolute 5-year CVD risk %   3.6 (0.4)  
Difference in post-AHC absolute 5-year CVD risk %   1.0 (0.4) 0.007§
Expected post-AHC absolute 10-year CVD risk % 9.5 (0.8) 10.2 (0.8) < 0.001
Observed post-AHC absolute 10-year CVD risk %   8.2 (0.7)  
Difference in post-AHC absolute 10-year CVD risk %   2.0 (0.7) 0.004§
  1. Notes: CVD = cardiovascular disease, AHC = adult health check, SE = standard error, N = number, HDL = high density lipoprotein, NZGG = New Zealand Guidelines Group.
  2. * Test for difference between findings at the AHC and at review. Means were tested by a paired two-tailed t-test. Proportions were tested using McNemar's test.
  3. † Cigarettes per day (cpd) categories: 1 = 5cpd, 2 = 10cpd, 3 = 15 cpd, 4 = 20+ cpd.
  4. ‡ NZGG risk categories: 4 = 10 to 15% over 5 years, 5 = 15 to 20% over 5 years, 6 = 20 to 25% over 5 years, etc.
  5. § Two-tailed t-test for difference between observed absolute CVD risk at post-AHC review and expected (change in age only) absolute CVD risk at post-AHC review.